Joint Replacements

Popularized by Sir John Charnley, MB, ChB, MRCS, LRCP, in the 1960s, total hip arthroplasty with a cemented femoral component was the standard of care for surgical treatment of osteoarthritis for several decades.

Bundled payment programs effectively reduced episode spending while maintaining quality of care in episodes of lower extremity joint replacement, according to results published in JAMA Health Forum.

Interleukin-1 inhibition with canakinumab may substantially reduce rates of total hip and knee replacement, as well as osteoarthritis symptoms, according to data published in the Annals of Internal Medicine.